• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Toluenes Toluamides

Recent Advances in the Study of N,N,3-Trimethylbenzamide (CAS: 6935-65-5): A Comprehensive Research Brief

N,N,3-Trimethylbenzamide (CAS: 6935-65-5) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug development, particularly as a precursor or intermediate in the synthesis of bioactive molecules. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its chemical properties, synthetic pathways, and biological activities.

One of the key areas of investigation has been the optimization of synthetic routes for N,N,3-Trimethylbenzamide. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an efficient, high-yield synthesis method using palladium-catalyzed cross-coupling reactions. This approach not only improved the scalability of the compound but also reduced the environmental impact compared to traditional methods. The study highlighted the compound's stability under various conditions, making it a viable candidate for further pharmaceutical applications.

In addition to its synthetic utility, N,N,3-Trimethylbenzamide has shown promise in biological assays. Research conducted at the University of Cambridge (2024) revealed that derivatives of this compound exhibit moderate inhibitory activity against certain kinases involved in inflammatory pathways. These findings suggest potential applications in the development of anti-inflammatory drugs, although further in vivo studies are required to validate these effects.

Another notable study, published in Bioorganic & Medicinal Chemistry Letters (2023), explored the structural-activity relationship (SAR) of N,N,3-Trimethylbenzamide analogs. The researchers identified specific modifications to the benzamide core that enhanced binding affinity to target proteins, providing valuable insights for future drug design efforts. Computational modeling and molecular docking studies were employed to predict the interaction mechanisms, which were subsequently confirmed through X-ray crystallography.

Despite these advancements, challenges remain in the practical application of N,N,3-Trimethylbenzamide. Issues such as solubility and bioavailability need to be addressed to fully exploit its therapeutic potential. Recent work by a team at MIT (2024) has focused on formulating the compound into nanoparticle carriers to improve its delivery and efficacy. Preliminary results are encouraging, with enhanced cellular uptake observed in vitro.

In conclusion, N,N,3-Trimethylbenzamide (CAS: 6935-65-5) continues to be a compound of interest in chemical biology and pharmaceutical research. Recent studies have expanded our understanding of its synthetic accessibility, biological activity, and potential therapeutic applications. Future research should focus on overcoming existing limitations and exploring novel derivatives to unlock its full potential in drug development.

• 134-62-3(Diethyltoluamide)
• 105394-85-2(Benzamide,N,N-diethyl-3-formyl-)
• 14062-78-3(Benzamide,N,N,4-trimethyl-)
• 141264-25-7(Benzamide,N-formyl-N-methyl-)
• 13698-87-8(NNN'N'-Tetraethylisophthalamide)
• 126926-36-1(3-formyl-N,N-dimethylbenzamide)
• 13158-31-1(1,4-Benzenedicarboxamide,N1,N1,N4,N4-tetramethyl-)
• 611-74-5(N,N-dimethylbenzamide)
• 1696-17-9(N,N-Diethylbenzamide)
• 15394-30-6(NNN'N'-Tetraethylterephthalamide)